Floatz logo

Estriol

Atrophic Vaginitis

ITF Research Pharma, S.L.U.Small moleculePhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Atrophic Vaginitis cohort.

Asset / SponsorPhaseRating
Prasterone
University Hospital, Ghent
Phase 4BB
PILOCARPINUM
Alliance for Clinical Trials in Oncology
Phase 3BB
AUTOLOGOUS CONDITIONED PLASMA
University of Miami
Phase 2B
Dhea
Hadassah Medical Organization
Phase 2/3B
Polycarbophil
University of Arkansas
Phase 2CCC
Prasterone
University of Arkansas
Phase 2CCC
TESTOSTERONE UNDECYLATE
Creighton University
Early Phase 1CC
Promestriene
Federal University of São Paulo
N/AD

Same molecule, other indications

Estriol is also rated in:

urinary bladder, atony ofDormant
B
Indicative ·
61 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
B
Indicative ·
57 / 100
View asset →
secondary progressive multiple sclerosisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →